Related Experiment Video
Updated: Jun 27, 2026

06:32
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
IFN-beta improves BCG immunogenicity by acting on DC maturation.
Elena Giacomini1, Maria Elena Remoli, Valérie Gafa
1Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy.
Journal of Leukocyte Biology
|December 6, 2008
Summary
New research shows that adding interferon-beta (IFN-beta) to dendritic cells (DC) infected with Mycobacterium bovis bacillus Calmette-Guérin (BCG) enhances their ability to stimulate a protective immune response, suggesting IFN-beta as a potential vaccine adjuvant for tuberculosis.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Tuberculosis (TB) vaccines require improved efficacy due to variable protection from current Mycobacterium bovis bacillus Calmette-Guérin (BCG).
- Dendritic cells (DCs) are crucial for initiating T cell responses against pathogens.
- Understanding how mycobacteria modulate DC function is key to developing new TB vaccine strategies.
Purpose of the Study:
- To compare the effects of Mycobacterium tuberculosis (Mtb) and BCG on DC immunophenotype and function.
- To investigate whether exogenous interferon-beta (IFN-beta) can enhance the Th1-polarizing capacity of BCG-infected DCs.
Main Methods:
- Comparative analysis of DC immunophenotype following infection with Mtb and BCG.
- Assessment of DC maturation markers, cytokine production (IFN-beta, IL-12), and transcription factor activation (IRF-3).
- In vitro pretreatment of BCG-infected DCs with exogenous IFN-beta to evaluate its effect on DC maturation and Th1 response.
Main Results:
- BCG infection induced less DC maturation, lower IFN-beta and IL-12 production compared to Mtb infection.
- BCG-induced impairment in IL-12 and IFN-beta expression was linked to reduced IRF-3 activation.
- Pretreatment of BCG-infected DCs with IFN-beta restored DC maturation and significantly enhanced IL-12p70 production, leading to a stronger Th1 response.
Conclusions:
- IFN-beta treatment potentiates the immunological functions of DCs infected with BCG.
- IFN-beta enhances the Th1-polarizing capacity of BCG-infected DCs, improving their potential as a vaccine adjuvant.
- IFN-beta represents a promising candidate adjuvant for improving BCG-based tuberculosis vaccines.
More Related Videos
Related Concept Videos
B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Vaccinations
Overview
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

